P1, N=15, Recruiting, Fred Hutchinson Cancer Center | Trial completion date: Sep 2024 --> Jun 2025 | Trial primary completion date: Dec 2023 --> Jun 2024
12 months ago
Trial completion date • Trial primary completion date • Metastases
|
HLA-A (Major Histocompatibility Complex, Class I, A) • MSLN (Mesothelin)
|
MSLN expression • HLA-A*02
|
cyclophosphamide • bendamustine • fludarabine IV • FH-TCR-Tᴍsʟɴ